Successful treatment of a patient with adult T cell leukemia/lymphoma using anti-CC chemokine receptor 4 monoclonal antibody mogamulizumab followed by ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2013-06-26

AUTHORS

Kenji Motohashi, Taisei Suzuki, Kumiko Kishimoto, Ayumi Numata, Yuki Nakajima, Takayoshi Tachibana, Rika Ohshima, Hideyuki Kuwabara, Masatsugu Tanaka, Naoto Tomita, Yoshiaki Ishigatsubo, Shin Fujisawa

ABSTRACT

Adult T cell leukemia/lymphoma (ATLL) is an aggressive peripheral T cell neoplasm caused by human T cell lymphotropic/leukemia virus type-1 and has a poor prognosis. A new anti-CC chemokine receptor 4 monoclonal antibody (mogamulizumab) has been shown to be effective for ATLL. Although mogamulizumab is now available in Japan for patients with ATLL, the influence on allogeneic hematopoietic stem cell transplantation (HSCT) remains unclear. Here we report a woman with ATLL resistant to combination chemotherapy, who achieved complete remission following treatment with mogamulizumab and subsequently received allogeneic HSCT. The patient has remained in complete remission with controlled graft-versus-host disease. To our knowledge, this is the first report of an ATLL patient who received mogamulizumab treatment followed by allogeneic HSCT. We suggest that administration of mogamulizumab to chemotherapy-resistant patients with ATLL may improve their disease status before allogeneic HSCT and result in better survival. More... »

PAGES

258-260

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12185-013-1387-8

DOI

http://dx.doi.org/10.1007/s12185-013-1387-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1018731755

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/23801427


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Allografts", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal, Humanized", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematopoietic Stem Cell Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia-Lymphoma, Adult T-Cell", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, CCR4", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Remission Induction", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Yokohama City University Medical Center, 4-57, Urafunecho, 232-0024, Minami-ku, Yokohama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.413045.7", 
          "name": [
            "Department of Hematology, Yokohama City University Medical Center, 4-57, Urafunecho, 232-0024, Minami-ku, Yokohama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Motohashi", 
        "givenName": "Kenji", 
        "id": "sg:person.0754707733.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0754707733.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Yokohama City University Medical Center, 4-57, Urafunecho, 232-0024, Minami-ku, Yokohama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.413045.7", 
          "name": [
            "Department of Hematology, Yokohama City University Medical Center, 4-57, Urafunecho, 232-0024, Minami-ku, Yokohama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Suzuki", 
        "givenName": "Taisei", 
        "id": "sg:person.01172722143.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01172722143.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Yokohama City University Medical Center, 4-57, Urafunecho, 232-0024, Minami-ku, Yokohama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.413045.7", 
          "name": [
            "Department of Hematology, Yokohama City University Medical Center, 4-57, Urafunecho, 232-0024, Minami-ku, Yokohama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kishimoto", 
        "givenName": "Kumiko", 
        "id": "sg:person.01104507702.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104507702.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Yokohama City University Medical Center, 4-57, Urafunecho, 232-0024, Minami-ku, Yokohama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.413045.7", 
          "name": [
            "Department of Hematology, Yokohama City University Medical Center, 4-57, Urafunecho, 232-0024, Minami-ku, Yokohama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Numata", 
        "givenName": "Ayumi", 
        "id": "sg:person.01224172631.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224172631.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Yokohama City University Medical Center, 4-57, Urafunecho, 232-0024, Minami-ku, Yokohama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.413045.7", 
          "name": [
            "Department of Hematology, Yokohama City University Medical Center, 4-57, Urafunecho, 232-0024, Minami-ku, Yokohama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nakajima", 
        "givenName": "Yuki", 
        "id": "sg:person.01135701435.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135701435.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Yokohama City University Medical Center, 4-57, Urafunecho, 232-0024, Minami-ku, Yokohama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.413045.7", 
          "name": [
            "Department of Hematology, Yokohama City University Medical Center, 4-57, Urafunecho, 232-0024, Minami-ku, Yokohama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tachibana", 
        "givenName": "Takayoshi", 
        "id": "sg:person.01074653417.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01074653417.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Yokohama City University Medical Center, 4-57, Urafunecho, 232-0024, Minami-ku, Yokohama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.413045.7", 
          "name": [
            "Department of Hematology, Yokohama City University Medical Center, 4-57, Urafunecho, 232-0024, Minami-ku, Yokohama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ohshima", 
        "givenName": "Rika", 
        "id": "sg:person.01105515016.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01105515016.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Yokohama City University Medical Center, 4-57, Urafunecho, 232-0024, Minami-ku, Yokohama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.413045.7", 
          "name": [
            "Department of Hematology, Yokohama City University Medical Center, 4-57, Urafunecho, 232-0024, Minami-ku, Yokohama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kuwabara", 
        "givenName": "Hideyuki", 
        "id": "sg:person.01224221720.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224221720.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Yokohama City University Medical Center, 4-57, Urafunecho, 232-0024, Minami-ku, Yokohama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.413045.7", 
          "name": [
            "Department of Hematology, Yokohama City University Medical Center, 4-57, Urafunecho, 232-0024, Minami-ku, Yokohama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tanaka", 
        "givenName": "Masatsugu", 
        "id": "sg:person.01171141246.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171141246.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.268441.d", 
          "name": [
            "Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tomita", 
        "givenName": "Naoto", 
        "id": "sg:person.01155656464.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155656464.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.268441.d", 
          "name": [
            "Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ishigatsubo", 
        "givenName": "Yoshiaki", 
        "id": "sg:person.01125133646.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125133646.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology, Yokohama City University Medical Center, 4-57, Urafunecho, 232-0024, Minami-ku, Yokohama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.413045.7", 
          "name": [
            "Department of Hematology, Yokohama City University Medical Center, 4-57, Urafunecho, 232-0024, Minami-ku, Yokohama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fujisawa", 
        "givenName": "Shin", 
        "id": "sg:person.01145377314.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145377314.06"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/bmt.2012.268", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013317804", 
          "https://doi.org/10.1038/bmt.2012.268"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02983215", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022520678", 
          "https://doi.org/10.1007/bf02983215"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12185-011-0941-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039839309", 
          "https://doi.org/10.1007/s12185-011-0941-5"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2013-06-26", 
    "datePublishedReg": "2013-06-26", 
    "description": "Adult T cell leukemia/lymphoma (ATLL) is an aggressive peripheral T cell neoplasm caused by human T cell lymphotropic/leukemia virus type-1 and has a poor prognosis. A new anti-CC chemokine receptor 4 monoclonal antibody (mogamulizumab) has been shown to be effective for ATLL. Although mogamulizumab is now available in Japan for patients with ATLL, the influence on allogeneic hematopoietic stem cell transplantation (HSCT) remains unclear. Here we report a woman with ATLL resistant to combination chemotherapy, who achieved complete remission following treatment with mogamulizumab and subsequently received allogeneic HSCT. The patient has remained in complete remission with controlled graft-versus-host disease. To our knowledge, this is the first report of an ATLL patient who received mogamulizumab treatment followed by allogeneic HSCT. We suggest that administration of mogamulizumab to chemotherapy-resistant patients with ATLL may improve their disease status before allogeneic HSCT and result in better survival.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s12185-013-1387-8", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1076985", 
        "issn": [
          "0925-5710", 
          "1865-3774"
        ], 
        "name": "International Journal of Hematology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "98"
      }
    ], 
    "keywords": [
      "allogeneic hematopoietic stem cell transplantation", 
      "adult T cell leukemia/lymphoma", 
      "hematopoietic stem cell transplantation", 
      "cell leukemia/lymphoma", 
      "stem cell transplantation", 
      "leukemia/lymphoma", 
      "complete remission", 
      "cell transplantation", 
      "anti-CC chemokine receptor 4 monoclonal antibody", 
      "administration of mogamulizumab", 
      "chemotherapy-resistant patients", 
      "cell lymphotropic/leukemia virus type 1", 
      "virus type 1", 
      "leukemia virus type 1", 
      "host disease", 
      "mogamulizumab treatment", 
      "combination chemotherapy", 
      "poor prognosis", 
      "ATLL patients", 
      "successful treatment", 
      "cell neoplasms", 
      "mogamulizumab", 
      "better survival", 
      "patients", 
      "disease status", 
      "type 1", 
      "monoclonal antibodies", 
      "remission", 
      "transplantation", 
      "lymphoma", 
      "treatment", 
      "first report", 
      "chemotherapy", 
      "prognosis", 
      "neoplasms", 
      "graft", 
      "disease", 
      "administration", 
      "antibodies", 
      "women", 
      "survival", 
      "report", 
      "status", 
      "knowledge", 
      "Japan", 
      "influence", 
      "T cell leukemia/lymphoma", 
      "lymphotropic/leukemia virus type-1", 
      "new anti-CC chemokine receptor 4 monoclonal antibody", 
      "chemokine receptor 4 monoclonal antibody", 
      "receptor 4 monoclonal antibody", 
      "anti-CC chemokine receptor 4 monoclonal antibody mogamulizumab", 
      "chemokine receptor 4 monoclonal antibody mogamulizumab", 
      "receptor 4 monoclonal antibody mogamulizumab", 
      "monoclonal antibody mogamulizumab", 
      "antibody mogamulizumab"
    ], 
    "name": "Successful treatment of a patient with adult T cell leukemia/lymphoma using anti-CC chemokine receptor 4 monoclonal antibody mogamulizumab followed by allogeneic hematopoietic stem cell transplantation", 
    "pagination": "258-260", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1018731755"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12185-013-1387-8"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "23801427"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12185-013-1387-8", 
      "https://app.dimensions.ai/details/publication/pub.1018731755"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:30", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_616.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s12185-013-1387-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12185-013-1387-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12185-013-1387-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12185-013-1387-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12185-013-1387-8'


 

This table displays all metadata directly associated to this object as RDF triples.

246 TRIPLES      22 PREDICATES      94 URIs      83 LITERALS      16 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12185-013-1387-8 schema:about N057ec5362cb547acbcfaeaa3f717d302
2 N0981c22b7361401a98a41f38e4953174
3 N3b7f0230024d4a548fd0f0d8190828b0
4 N4b34c6f702eb4ea1a2c66cd2a7473c9f
5 N6cd5db8c02c4427cb55102e8879dd4ac
6 Nc2fe541d322942da8c63652522c42f81
7 Ne8f8c3af9ad644549321c8a226051592
8 Neaebdaba5dd04707b917bc269385eb12
9 Nf06a6ee4b78249b9b490e4c203dbd988
10 anzsrc-for:11
11 anzsrc-for:1112
12 schema:author N2b5f70941740481f9636b98fef5595f5
13 schema:citation sg:pub.10.1007/bf02983215
14 sg:pub.10.1007/s12185-011-0941-5
15 sg:pub.10.1038/bmt.2012.268
16 schema:datePublished 2013-06-26
17 schema:datePublishedReg 2013-06-26
18 schema:description Adult T cell leukemia/lymphoma (ATLL) is an aggressive peripheral T cell neoplasm caused by human T cell lymphotropic/leukemia virus type-1 and has a poor prognosis. A new anti-CC chemokine receptor 4 monoclonal antibody (mogamulizumab) has been shown to be effective for ATLL. Although mogamulizumab is now available in Japan for patients with ATLL, the influence on allogeneic hematopoietic stem cell transplantation (HSCT) remains unclear. Here we report a woman with ATLL resistant to combination chemotherapy, who achieved complete remission following treatment with mogamulizumab and subsequently received allogeneic HSCT. The patient has remained in complete remission with controlled graft-versus-host disease. To our knowledge, this is the first report of an ATLL patient who received mogamulizumab treatment followed by allogeneic HSCT. We suggest that administration of mogamulizumab to chemotherapy-resistant patients with ATLL may improve their disease status before allogeneic HSCT and result in better survival.
19 schema:genre article
20 schema:inLanguage en
21 schema:isAccessibleForFree false
22 schema:isPartOf N62ed3ceed64543ceb99f9e6ac78c2152
23 Nf6a68f71154342fabb7a02373472f94d
24 sg:journal.1076985
25 schema:keywords ATLL patients
26 Japan
27 T cell leukemia/lymphoma
28 administration
29 administration of mogamulizumab
30 adult T cell leukemia/lymphoma
31 allogeneic hematopoietic stem cell transplantation
32 anti-CC chemokine receptor 4 monoclonal antibody
33 anti-CC chemokine receptor 4 monoclonal antibody mogamulizumab
34 antibodies
35 antibody mogamulizumab
36 better survival
37 cell leukemia/lymphoma
38 cell lymphotropic/leukemia virus type 1
39 cell neoplasms
40 cell transplantation
41 chemokine receptor 4 monoclonal antibody
42 chemokine receptor 4 monoclonal antibody mogamulizumab
43 chemotherapy
44 chemotherapy-resistant patients
45 combination chemotherapy
46 complete remission
47 disease
48 disease status
49 first report
50 graft
51 hematopoietic stem cell transplantation
52 host disease
53 influence
54 knowledge
55 leukemia virus type 1
56 leukemia/lymphoma
57 lymphoma
58 lymphotropic/leukemia virus type-1
59 mogamulizumab
60 mogamulizumab treatment
61 monoclonal antibodies
62 monoclonal antibody mogamulizumab
63 neoplasms
64 new anti-CC chemokine receptor 4 monoclonal antibody
65 patients
66 poor prognosis
67 prognosis
68 receptor 4 monoclonal antibody
69 receptor 4 monoclonal antibody mogamulizumab
70 remission
71 report
72 status
73 stem cell transplantation
74 successful treatment
75 survival
76 transplantation
77 treatment
78 type 1
79 virus type 1
80 women
81 schema:name Successful treatment of a patient with adult T cell leukemia/lymphoma using anti-CC chemokine receptor 4 monoclonal antibody mogamulizumab followed by allogeneic hematopoietic stem cell transplantation
82 schema:pagination 258-260
83 schema:productId N0755f732a29d48c49b53eb6af5bfca61
84 N86b3913b9b1742078e31e665854e3788
85 Nb32ad58f0741431486a477159d9547cf
86 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018731755
87 https://doi.org/10.1007/s12185-013-1387-8
88 schema:sdDatePublished 2021-12-01T19:30
89 schema:sdLicense https://scigraph.springernature.com/explorer/license/
90 schema:sdPublisher N9b2f9cf7113d4c5ab3b46cb05e8e166b
91 schema:url https://doi.org/10.1007/s12185-013-1387-8
92 sgo:license sg:explorer/license/
93 sgo:sdDataset articles
94 rdf:type schema:ScholarlyArticle
95 N057ec5362cb547acbcfaeaa3f717d302 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Leukemia-Lymphoma, Adult T-Cell
97 rdf:type schema:DefinedTerm
98 N0755f732a29d48c49b53eb6af5bfca61 schema:name pubmed_id
99 schema:value 23801427
100 rdf:type schema:PropertyValue
101 N0981c22b7361401a98a41f38e4953174 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Remission Induction
103 rdf:type schema:DefinedTerm
104 N2b5f70941740481f9636b98fef5595f5 rdf:first sg:person.0754707733.37
105 rdf:rest N2d55f0c93b0141749fba2280b0dd0565
106 N2ceabe41a7a64595bb9e10be249a959d rdf:first sg:person.01224221720.96
107 rdf:rest N3f4bfb165c28473ca1444b39d646ac13
108 N2d55f0c93b0141749fba2280b0dd0565 rdf:first sg:person.01172722143.00
109 rdf:rest Nf85e6e76a29b49d8b7fd4016e3fb436a
110 N3b7f0230024d4a548fd0f0d8190828b0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Female
112 rdf:type schema:DefinedTerm
113 N3f4bfb165c28473ca1444b39d646ac13 rdf:first sg:person.01171141246.33
114 rdf:rest Ne1625e7875d749f1b5188ae11cb0fc77
115 N464f9656f45b4ce0bb8e63a5c602c86b rdf:first sg:person.01074653417.74
116 rdf:rest N68eaea4136d54d78b0dc720520fdee23
117 N4b34c6f702eb4ea1a2c66cd2a7473c9f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Middle Aged
119 rdf:type schema:DefinedTerm
120 N62ed3ceed64543ceb99f9e6ac78c2152 schema:issueNumber 2
121 rdf:type schema:PublicationIssue
122 N68eaea4136d54d78b0dc720520fdee23 rdf:first sg:person.01105515016.46
123 rdf:rest N2ceabe41a7a64595bb9e10be249a959d
124 N6cd5db8c02c4427cb55102e8879dd4ac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Antibodies, Monoclonal, Humanized
126 rdf:type schema:DefinedTerm
127 N80499bd86599480eae283d40c77ee781 rdf:first sg:person.01224172631.55
128 rdf:rest Nba4658e9c7274b9d80f32f168347b695
129 N8551c7bae3c441c99844fd08ddecffcb rdf:first sg:person.01125133646.44
130 rdf:rest N9d58ba0ee2534b92ad71c83ba9186f77
131 N86b3913b9b1742078e31e665854e3788 schema:name dimensions_id
132 schema:value pub.1018731755
133 rdf:type schema:PropertyValue
134 N9b2f9cf7113d4c5ab3b46cb05e8e166b schema:name Springer Nature - SN SciGraph project
135 rdf:type schema:Organization
136 N9d58ba0ee2534b92ad71c83ba9186f77 rdf:first sg:person.01145377314.06
137 rdf:rest rdf:nil
138 Nb32ad58f0741431486a477159d9547cf schema:name doi
139 schema:value 10.1007/s12185-013-1387-8
140 rdf:type schema:PropertyValue
141 Nba4658e9c7274b9d80f32f168347b695 rdf:first sg:person.01135701435.52
142 rdf:rest N464f9656f45b4ce0bb8e63a5c602c86b
143 Nc2fe541d322942da8c63652522c42f81 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Hematopoietic Stem Cell Transplantation
145 rdf:type schema:DefinedTerm
146 Ne1625e7875d749f1b5188ae11cb0fc77 rdf:first sg:person.01155656464.01
147 rdf:rest N8551c7bae3c441c99844fd08ddecffcb
148 Ne8f8c3af9ad644549321c8a226051592 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Allografts
150 rdf:type schema:DefinedTerm
151 Neaebdaba5dd04707b917bc269385eb12 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Humans
153 rdf:type schema:DefinedTerm
154 Nf06a6ee4b78249b9b490e4c203dbd988 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Receptors, CCR4
156 rdf:type schema:DefinedTerm
157 Nf6a68f71154342fabb7a02373472f94d schema:volumeNumber 98
158 rdf:type schema:PublicationVolume
159 Nf85e6e76a29b49d8b7fd4016e3fb436a rdf:first sg:person.01104507702.59
160 rdf:rest N80499bd86599480eae283d40c77ee781
161 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
162 schema:name Medical and Health Sciences
163 rdf:type schema:DefinedTerm
164 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
165 schema:name Oncology and Carcinogenesis
166 rdf:type schema:DefinedTerm
167 sg:journal.1076985 schema:issn 0925-5710
168 1865-3774
169 schema:name International Journal of Hematology
170 schema:publisher Springer Nature
171 rdf:type schema:Periodical
172 sg:person.01074653417.74 schema:affiliation grid-institutes:grid.413045.7
173 schema:familyName Tachibana
174 schema:givenName Takayoshi
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01074653417.74
176 rdf:type schema:Person
177 sg:person.01104507702.59 schema:affiliation grid-institutes:grid.413045.7
178 schema:familyName Kishimoto
179 schema:givenName Kumiko
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104507702.59
181 rdf:type schema:Person
182 sg:person.01105515016.46 schema:affiliation grid-institutes:grid.413045.7
183 schema:familyName Ohshima
184 schema:givenName Rika
185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01105515016.46
186 rdf:type schema:Person
187 sg:person.01125133646.44 schema:affiliation grid-institutes:grid.268441.d
188 schema:familyName Ishigatsubo
189 schema:givenName Yoshiaki
190 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125133646.44
191 rdf:type schema:Person
192 sg:person.01135701435.52 schema:affiliation grid-institutes:grid.413045.7
193 schema:familyName Nakajima
194 schema:givenName Yuki
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135701435.52
196 rdf:type schema:Person
197 sg:person.01145377314.06 schema:affiliation grid-institutes:grid.413045.7
198 schema:familyName Fujisawa
199 schema:givenName Shin
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145377314.06
201 rdf:type schema:Person
202 sg:person.01155656464.01 schema:affiliation grid-institutes:grid.268441.d
203 schema:familyName Tomita
204 schema:givenName Naoto
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155656464.01
206 rdf:type schema:Person
207 sg:person.01171141246.33 schema:affiliation grid-institutes:grid.413045.7
208 schema:familyName Tanaka
209 schema:givenName Masatsugu
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171141246.33
211 rdf:type schema:Person
212 sg:person.01172722143.00 schema:affiliation grid-institutes:grid.413045.7
213 schema:familyName Suzuki
214 schema:givenName Taisei
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01172722143.00
216 rdf:type schema:Person
217 sg:person.01224172631.55 schema:affiliation grid-institutes:grid.413045.7
218 schema:familyName Numata
219 schema:givenName Ayumi
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224172631.55
221 rdf:type schema:Person
222 sg:person.01224221720.96 schema:affiliation grid-institutes:grid.413045.7
223 schema:familyName Kuwabara
224 schema:givenName Hideyuki
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224221720.96
226 rdf:type schema:Person
227 sg:person.0754707733.37 schema:affiliation grid-institutes:grid.413045.7
228 schema:familyName Motohashi
229 schema:givenName Kenji
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0754707733.37
231 rdf:type schema:Person
232 sg:pub.10.1007/bf02983215 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022520678
233 https://doi.org/10.1007/bf02983215
234 rdf:type schema:CreativeWork
235 sg:pub.10.1007/s12185-011-0941-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039839309
236 https://doi.org/10.1007/s12185-011-0941-5
237 rdf:type schema:CreativeWork
238 sg:pub.10.1038/bmt.2012.268 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013317804
239 https://doi.org/10.1038/bmt.2012.268
240 rdf:type schema:CreativeWork
241 grid-institutes:grid.268441.d schema:alternateName Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
242 schema:name Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
243 rdf:type schema:Organization
244 grid-institutes:grid.413045.7 schema:alternateName Department of Hematology, Yokohama City University Medical Center, 4-57, Urafunecho, 232-0024, Minami-ku, Yokohama, Japan
245 schema:name Department of Hematology, Yokohama City University Medical Center, 4-57, Urafunecho, 232-0024, Minami-ku, Yokohama, Japan
246 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...